What is the vesting schedule of Alan Chippindale’s 6,032-share award at Stran & Company (SWAG)?

The 6,032-share award vests in four equal installments of 1,508 shares each on September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027, according to the footnote in the Form 4.

Stran & Company director granted 6,032 SWAG shares

Q: What did Stran & Company (SWAG) disclose about Alan Chippindale’s new stock grant?

Stran & Company disclosed that director Alan Chippindale received a grant of 6,032 shares of common stock on August 13, 2026, as a compensation award, increasing his direct holdings to 46,373 shares after the transaction.

Q: How many Stran & Company (SWAG) shares does Alan Chippindale hold after this Form 4 transaction?

After the reported grant, Alan Chippindale directly holds 46,373 shares of Stran & Company common stock. This reflects the addition of a 6,032-share compensation award reported in the Form 4 filed for August 13, 2026.

Q: Was Alan Chippindale’s Stran & Company (SWAG) stock transaction a market purchase or a grant?

The Form 4 identifies the transaction as a grant, award, or other acquisition of 6,032 shares at a stated price of $0.00 per share, indicating it is a compensation award, not an open-market purchase or sale.

Chippindale Alan reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Chippindale Alan reported acquisition or exercise transactions in this Form 4 filing.

Stran & Company, Inc. reported that director Alan Chippindale received a grant of 6,032 shares of common stock on August 13, 2026. The grant was at a stated price of $0.00 per share, reflecting a compensation award rather than an open-market purchase. Following this award, Chippindale’s direct holdings increased to 46,373 common shares.

The award is subject to a time-based vesting schedule: it vests as to 1,508 shares on each of September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027. The filing does not indicate use of a Rule 10b5-1 trading plan for this grant.

Insider Trade Summary

Grant/Award: 6,032 shares

Grant/Award 1 txn

Insider Chippindale Alan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^F1	6,032	$0.00	$0.00

Holdings After Transaction: Common Stock — 46,373 shares (Direct)

Footnotes (1)

F1. Vests as to 1,508 shares on each of September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027.

Key Figures

Shares granted: 6,032 shares of common stock Price per share: $0.00 per share Holdings after transaction: 46,373 shares +4 more

7 metrics

Shares granted 6,032 shares of common stock Grant, award, or other acquisition on August 13, 2026

Price per share $0.00 per share Stated transaction price for the 6,032-share award

Holdings after transaction 46,373 shares Total direct common stock holdings following the award

First vesting installment 1,508 shares Vests on September 30, 2026

Second vesting installment 1,508 shares Vests on December 31, 2026

Third vesting installment 1,508 shares Vests on March 31, 2027

Fourth vesting installment 1,508 shares Vests on June 30, 2027

Key Terms

Grant, award, or other acquisition, vesting schedule, non-derivative

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

vesting schedule financial

"The award is subject to a time-based vesting schedule"

A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

non-derivative financial

"The Form 4 shows only a non-derivative acquisition"

FAQ

What did Stran & Company (SWAG) disclose about Alan Chippindale’s new stock grant?

Stran & Company disclosed that director Alan Chippindale received a grant of 6,032 shares of common stock on August 13, 2026, as a compensation award, increasing his direct holdings to 46,373 shares after the transaction.

How many Stran & Company (SWAG) shares does Alan Chippindale hold after this Form 4 transaction?

After the reported grant, Alan Chippindale directly holds 46,373 shares of Stran & Company common stock. This reflects the addition of a 6,032-share compensation award reported in the Form 4 filed for August 13, 2026.

Was Alan Chippindale’s Stran & Company (SWAG) stock transaction a market purchase or a grant?

The Form 4 identifies the transaction as a grant, award, or other acquisition of 6,032 shares at a stated price of $0.00 per share, indicating it is a compensation award, not an open-market purchase or sale.

Does the Alan Chippindale Form 4 for Stran & Company (SWAG) involve any derivative securities?

No derivative securities are reported. The Form 4 shows only a non-derivative acquisition of 6,032 shares of common stock, with no options or other derivatives listed in the derivative summary section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/14/2026 - 04:34 PM Accepted by SEC EDGAR 08/14/2026 - 04:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chippindale Alan

(Last)

(First)

(Middle)

C/O STRAN & COMPANY, INC.

500 VICTORY ROAD, SUITE 301

(Street)

QUINCY

MASSACHUSETTS

02171

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Stran & Company, Inc. [ SWAG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/13/2026		A		6,032⁽¹⁾	A	$0	46,373	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Vests as to 1,508 shares on each of September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027.

	/s/ Alan Chippindale	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR